Similar articles

• [On the biological characteristics of the serum of schizophrenic patients].

  Krasnova AI, Lozovskiĭ DB, Fakor MI. Krasnova AI, et al. Zh Nevropatol Psikhiatr Im S S Korsakova. 1966;66(10):1538-42. Zh Nevropatol Psikhiatr Im S S Korsakova. 1966. PMID: 6012050 Russian. No abstract available.
• Plasma factors, amines and their derivatives in schizophrenia.

  Bergen JR. Bergen JR. Res Commun Chem Pathol Pharmacol. 1970 May;1(3):403-18. Res Commun Chem Pathol Pharmacol. 1970. PMID: 4944700 Review. No abstract available.
• Plasma proteins in schizophrenia: a review.

  Durell J, Archer EG. Durell J, et al. Schizophr Bull. 1976;2(1):147-59. doi: 10.1093/schbul/2.1.147. Schizophr Bull. 1976. PMID: 59383 Review. No abstract available.
• Amino acid transport and the plasma factor in schizophrenia.

  Frohman CE, Warner KA, Barry CT, Arthur RE. Frohman CE, et al. Biol Psychiatry. 1969 Jul;1(3):201-7. Biol Psychiatry. 1969. PMID: 4187516 No abstract available.
• The pharmacology of 4H-3-methylcarboxyamide-1,3-benzoxazine-2-one (F.I. 6654), a compound acting on the central nervous system.

  Suchowsky GK, Pegrassi L. Suchowsky GK, et al. Arzneimittelforschung. 1969 Apr;19(4):643-8. Arzneimittelforschung. 1969. PMID: 4977576 No abstract available.